Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tourmaline Bio (TRML)
NASDAQ:TRML
Tourmaline Bio (TRML) Stock Price & Analysis
199 Followers
TRML Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.68 - $48.31
Previous Close$22.9
Volume674.94K
Average Volume (3M)355.44K
Market Cap
$587.31M
Enterprise Value$384.77M
Total Cash (Recent Filing)$202.95M
Total Debt (Recent Filing)$415.00K
Price to Earnings (P/E)-2.0
Beta1.44
Next Earnings
Mar 19, 2024EPS Estimate
-$0.71Last Dividend Ex-Date
Oct 20, 2023Dividend Yield63.47%
Share Statistics
EPS (TTM)-11.32
Shares Outstanding25,646,509
10 Day Avg. Volume994,907
30 Day Avg. Volume355,438
Standard Deviation0.27
R-Squared0.19
Alpha0.00182
Financial Highlights & Ratios
Price to Book (P/B)2.98
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)13.90
P/FCF Ratio14.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-8.73
Forecast
1Y Price Target
$56.80Price Target Upside148.03% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Tourmaline Bio News
Ownership Overview
Currently, No data available
---
TRML FAQ
What was Tourmaline Bio’s price range in the past 12 months?
Tourmaline Bio lowest stock price was $7.68 and its highest was $48.31 in the past 12 months.
What is Tourmaline Bio’s market cap?
Currently, no data Available
When is Tourmaline Bio’s upcoming earnings report date?
Tourmaline Bio’s upcoming earnings report date is Mar 19, 2024 which is 44 days ago.
How were Tourmaline Bio’s earnings last quarter?
Currently, no data Available
Is Tourmaline Bio overvalued?
According to Wall Street analysts Tourmaline Bio’s price is currently Undervalued.
Does Tourmaline Bio pay dividends?
Tourmaline Bio pays a Notavailable dividend of $1.51 which represents an annual dividend yield of 63.47%. See more information on Tourmaline Bio dividends here
What is Tourmaline Bio’s EPS estimate?
Tourmaline Bio’s EPS estimate is -$0.71.
How many shares outstanding does Tourmaline Bio have?
Tourmaline Bio has 25,646,510 shares outstanding.
What happened to Tourmaline Bio’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Tourmaline Bio?
Among the largest hedge funds holding Tourmaline Bio’s share is RA Capital Management. It holds Tourmaline Bio’s shares valued at N/A.
---
Tourmaline Bio Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$56.80 (148.03% Upside)
$56.80 (148.03% Upside)
Hedge Fund Trend
Decreased
By 1.0M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $3.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 7.8%
Last 30 Days ▲ 0.1%
Last 30 Days ▲ 0.1%
Technicals
SMA
Positive
20 days / 200 days
Momentum
191.27%
12-Months-Change
Fundamentals
Return on Equity
-29.68%
Trailing 12-Months
Asset Growth
8.56%
Trailing 12-Months
Company Description
Tourmaline Bio
Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders.
---
TRML Stock 12 Months Forecast
Average Price Target
$56.80
▲(148.03% Upside)
Technical Analysis
Best Analysts Covering TRML
1 Year
1 Year Success Rate
2/3 ratings generated profit
1 Year Average Return
+19.03%
reiterated a buy rating 3 months ago
Copying Yasmeen Rahimi's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +19.03% per trade.
---